[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338341-105":59,"doc-detail-338341-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","treatment-indicators-and-prognostic-factors-in-colorectal-neuroendocrine-neoplasms-and-adenocarcinoma-with-neuroendocrine-differentiation-single-center-retrospective-study","Treatment indicators and prognostic factors in colorectal neuroendocrine neoplasms and adenocarcinoma with neuroendocrine differentiation - single center retrospective study","","Study objectives compare survival and metastasis patterns between colorectal neuroendocrine neoplasms (cNEN) and colorectal adenocarcinoma with neuroendocrine differentiation (cNED), and assess prognostic factors and treatment indicators. A retrospective cohort of patients diagnosed at West China Hospital from 2009–2020 evaluated diagnosis, metastasis rates, progression-free survival via Cox regression in surgical cNEN, and metastatic disease via generalized linear regression. Results include 435 patients with higher metastasis in MiNEN and NEC than NET and NED, and key independent risks linked to tumor grade, colon location, size, and CK20.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/treatment-indicators-and-prognostic-factors-in-colorectal-neuroendocrine-neoplasms-and-adenocarcinoma-with-neuroendocrine-differentiation-single-center-retrospective-study/338341/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/treatment-indicators-and-prognostic-factors-in-colorectal-neuroendocrine-neoplasms-and-adenocarcinoma-with-neuroendocrine-differentiation-single-center-retrospective-study/338341.png","ImageObject",300,407,{"name":92,"@type":93},"Sage","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-10","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the purpose of the study comparing cNEN and cNED?","Question",{"text":112,"@type":113},"The study compares survival and metastasis occurrence between cNEN and cNED, and further explores prognostic factors and treatment indicators.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were patients selected and how were diagnoses classified?",{"text":117,"@type":113},"Patients with cNEN and cNED diagnosed at West China Hospital from January 2009 to December 2020 were enrolled. Diagnoses used morphology and expression of neuroendocrine differentiation markers for NEN, while MiNEN required the neuroendocrine component to exceed 30% and NED required adenocarcinoma morphology plus at least one neuroendocrine differentiation marker.",{"name":119,"@type":110,"acceptedAnswer":120},"Which groups showed higher metastasis rates and where did metastases primarily occur?",{"text":121,"@type":113},"Metastasis rates were higher in MiNEN and NEC than in NET and NED. The liver was the main metastatic site in cNEN, while cNED metastasized to various sites.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338341,1790119019,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687197207057,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","International Journal of Colorectal Disease (2024) 39:170  \n[https://doi.org/10.1007/s00384-024-04731-7](https://doi.org/10.1007/s00384-024-04731-7)  \nTreatment indicators and prognostic factors in colorectal neuroendocrine neoplasms and adenocarcinoma with neuroendocrine differentiation: a single center retrospective study  \nXiaoying Fu1,2 · Cun Wang1,2 · Yongyang Yu1,2,3 · Hai‑Ning Chen1,2  \nAccepted: 1 October 2024 / Published online: 22 October 2024 © The Author(s) 2024  \nAbstract  \nPurpose This study compared survival and metastasis occurrence between colorectal neuroendocrine neoplasms (cNEN) and colorectal adenocarcinoma with neuroendocrine differentiation (cNED) and further explored their prognostic factors and treatment indicators.  \nMethods Patients diagnosed as cNEN and cNED in West China Hospital from January 2009 to December 2020 were enrolled. The diagnosis and metastasis rates were calculated. Univariate and multivariate Cox analyses were conducted for progression-free survival (PFS) in cNEN surgical patients, and generalized linear regression was used for metastatic disease. Result The study enrolled 435 patients, including 257 neuroendocrine tumors (NET), 52 neuroendocrine carcinomas (NEC), 29 mixed neuroendocrine-non-neuroendocrine neoplasms (MiNEN), and 97 NED patients, of whom 202 received local resection, and 233 received radical resection. Metastasis rates were higher in MiNEN and NEC groups compared to other groups (NED: 28.9%, MiNEN: 58.6%, NEC: 65.4%, NET: 8.6%, p \u003C 0.001) . The liver is the main metastatic site in cNEN, whereas cNED metastasized to various sites. For NEC and MiNEN patients, colon location (p = 0.002) and T stage >2 (p = 0.040) were associated with disease progression separately. Independent risk factors for metastatic NET included tumor grade G2/ G3 (p \u003C 0.001), colon location (p = 0.001), size ≥ 1 cm (p = 0.005), and CK20 partial positive (p \u003C 0.001) .  \nConclusion cNEN show high metastatic capacity and are challenging to diagnose. More aggressive treatment and follow-up strategies are necessary for those patients. NET tumor grade higher than G2, size larger than 1 cm, or located in the colon should be managed with radical surgery.  \nKeyword Neuroendocrine neoplasms · Metastasis · Surgery · Oncological outcomes  \n* Hai-Ning Chen[hnchen@scu.edu.cn](hnchen@scu.edu.cn)  \n1 Colorectal Cancer Center, Department of General Surgery, West China Hospital, Sichuan University, No. 37 Guo Xue Xiang Street, Chengdu 610041, Sichuan, China  \n2 Institute of Digestive Surgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, No. 37 Guo Xue Xiang Street, Chengdu 610041, Sichuan, China  \n3 General Surgery Depart. 2 (Colorectal Gastrointestinal Surgery), West China Tianfu Hospital, Sichuan University, Chengdu, Sichuan, China  \nIntroduction  \nColorectal neuroendocrine neoplasms (cNEN) represent a rare group of colorectal tumor subtypes, with incidence rates increasing over the past two decades [1] . According to the 2022 WHO Classification of Neuroendocrine Neoplasms, neuroendocrine neoplasms are classified into neuroendocrine tumors (NET), neuroendocrine carcinomas (NEC), and mixed neuroendocrine-non-neuroendocrine neoplasms (MiNEN) [2] . Historically, cNEC and cMiNEN have been managed and monitored similarly to colorectal adenocarcinomas (AD) in patients suitable for radical surgery. However, their prognosis has consistently lagged behind that of adenocarcinomas, highlighting the need to identify risk factors for poor outcomes and to improve perioperative treatment strategies [3, 4] . Moreover, low-to mediumgrade cNET also demonstrates malignant behaviors such as  \nmetastasis to distant organs and drug resistance [5] . Comparing the prognosis of cNET with NEC and MiNEN is necessary to enhance clinical awareness.  \nTreatment plans for cNET also vary significantly from those for cNEC and cMiNEN. Moreover, clinical guidelines for cNET management are inconsiste","cbCaihdD3wMOStZY","https://ap.wps.com/l/cbCaihdD3wMOStZY","pdf",2150131,11,"English","# Abstract\n# Introduction\n# Materials and methods","[{\"question\":\"What is the purpose of the study comparing cNEN and cNED?\",\"answer\":\"The study compares survival and metastasis occurrence between cNEN and cNED, and further explores prognostic factors and treatment indicators.\"},{\"question\":\"How were patients selected and how were diagnoses classified?\",\"answer\":\"Patients with cNEN and cNED diagnosed at West China Hospital from January 2009 to December 2020 were enrolled. Diagnoses used morphology and expression of neuroendocrine differentiation markers for NEN, while MiNEN required the neuroendocrine component to exceed 30% and NED required adenocarcinoma morphology plus at least one neuroendocrine differentiation marker.\"},{\"question\":\"Which groups showed higher metastasis rates and where did metastases primarily occur?\",\"answer\":\"Metastasis rates were higher in MiNEN and NEC than in NET and NED. The liver was the main metastatic site in cNEN, while cNED metastasized to various sites.\"}]","Treatment indicators and prognostic factors in colorectal neuroendocrine neoplasms and adenocarcinoma with neuroendocrine differentiation - single center retrospective study | PDF",1790023140,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dc0d34eccee91937469cc31459d23328.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/545c8a75914fba1b1e3e6eb0a7b859a1.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c4a396694ca944567f4b462caafcab7e.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c0fff133d96aa2e8bc9c3353aab19df7.webp",980,1301]